ATI N180 Pharmacology Exam | Nurselytic

Questions 60

ATI RN

ATI RN Test Bank

ATI N180 Pharmacology Exam Questions

Extract:


Question 1 of 5

A nurse is providing an in-service on raloxifene (Evista) to a group of female clients. What is the pregnancy risk category of raloxifene (Evista)?

Correct Answer: D

Rationale: The correct answer is D: Pregnancy Risk Category D. Raloxifene has been classified as Category D due to potential risks to the fetus, as studies have shown adverse effects in animal studies. Category A is the safest category, where adequate and well-controlled studies in pregnant women have not shown any risk to the fetus. Category B indicates no evidence of risk in humans, but animal studies have shown adverse effects. Category C means there is no adequate human studies, but animal studies have shown adverse effects.
Therefore, D is the correct choice for raloxifene, indicating potential risks to the fetus based on animal studies.

Question 2 of 5

Correct Answer:

Rationale:

Question 3 of 5

Correct Answer:

Rationale:

Question 4 of 5

Correct Answer:

Rationale:

Question 5 of 5

Correct Answer:

Rationale:

Similar Questions

Access More Questions!

ATI RN Basic


$89/ 30 days

 

ATI RN Premium


$150/ 90 days